Literature DB >> 16849963

Role of alcohol in determining human immunodeficiency virus (HIV)-relevant outcomes: A conceptual model to guide the implementation of evidence-based interventions into practice.

Joseph Conigliaro1, Amy C Justice, Adam J Gordon, Kendall Bryant.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16849963     DOI： 10.1097/01.mlr.0000223659.36369.cf

Source DB:  PubMed          Journal:  Med Care        ISSN： 0025-7079            Impact factor:   2.983


× No keyword cloud information.
  36 in total

1.  Selective neurocognitive deficits and poor life functioning are associated with significant depressive symptoms in alcoholism-HIV infection comorbidity.

Authors:  Stephanie A Sassoon; Margaret J Rosenbloom; Rosemary Fama; Edith V Sullivan; Adolf Pfefferbaum
Journal:  Psychiatry Res       Date:  2012-05-29       Impact factor: 3.222

Review 2.  The neuropsychology of HIV/AIDS in older adults.

Authors:  David J Hardy; David E Vance
Journal:  Neuropsychol Rev       Date:  2009-02-27       Impact factor: 7.444

3.  Anxiety sensitivity and hazardous drinking among persons living with HIV/AIDS: An examination of the role of emotion dysregulation.

Authors:  Daniel J Paulus; Charles Jardin; Jafar Bakhshaie; Carla Sharp; Steven Paul Woods; Chad Lemaire; Amy Leonard; Clayton Neighbors; Charles P Brandt; Michael J Zvolensky
Journal:  Addict Behav       Date:  2016-07-21       Impact factor: 3.913

4.  Emotion Dysregulation: An Explanatory Construct in the Relation Between HIV-Related Stigma and Hazardous Drinking among Persons Living with HIV/AIDS.

Authors:  Celia C Y Wong; Daniel J Paulus; Chad Lemaire; Amy Leonard; Carla Sharp; Clayton Neighbors; Charles P Brandt; Michael J Zvolensky
Journal:  Stigma Health       Date:  2018-06-07

5.  The Starting Treatment for Ethanol in Primary care Trials (STEP Trials): Protocol for Three Parallel Multi-Site Stepped Care Effectiveness Studies for Unhealthy Alcohol Use in HIV-Positive Patients.

Authors:  E Jennifer Edelman; Stephen A Maisto; Nathan B Hansen; Christopher J Cutter; James Dziura; Lynn E Fiellin; Patrick G O'Connor; Roger Bedimo; Cynthia Gibert; Vincent C Marconi; David Rimland; Maria C Rodriguez-Barradas; Michael S Simberkoff; Amy C Justice; Kendall J Bryant; David A Fiellin
Journal:  Contemp Clin Trials       Date:  2016-11-20       Impact factor: 2.226

6.  Remote semantic memory for public figures in HIV infection, alcoholism, and their comorbidity.

Authors:  Rosemary Fama; Margaret J Rosenbloom; Stephanie A Sassoon; Megan A Thompson; Adolf Pfefferbaum; Edith V Sullivan
Journal:  Alcohol Clin Exp Res       Date:  2010-12-01       Impact factor: 3.455

7.  Patterns of drug use and abuse among aging adults with and without HIV: a latent class analysis of a US Veteran cohort.

Authors:  Traci C Green; Trace Kershaw; Haiqun Lin; Robert Heimer; Joseph L Goulet; Kevin L Kraemer; Adam J Gordon; Steve A Maisto; Nancy L Day; Kendall Bryant; David A Fiellin; Amy C Justice
Journal:  Drug Alcohol Depend       Date:  2010-04-15       Impact factor: 4.492

8.  Medical service use among individuals receiving HIV prevention services in Los Angeles County.

Authors:  Erlyana Erlyana; Dennis G Fisher; Grace L Reynolds; Michael Jansen
Journal:  J Health Hum Serv Adm       Date:  2014

9.  Impairments in Component Processes of Executive Function and Episodic Memory in Alcoholism, HIV Infection, and HIV Infection with Alcoholism Comorbidity.

Authors:  Rosemary Fama; Edith V Sullivan; Stephanie A Sassoon; Adolf Pfefferbaum; Natalie M Zahr
Journal:  Alcohol Clin Exp Res       Date:  2016-10-19       Impact factor: 3.455

10.  Quality of HIV Care and Mortality Rates in HIV-Infected Patients.

Authors:  Philip Todd Korthuis; Kathleen A McGinnis; Kevin L Kraemer; Adam J Gordon; Melissa Skanderson; Amy C Justice; Stephen Crystal; Matthew Bidwell Goetz; Cynthia L Gibert; David Rimland; Lynn E Fiellin; Julie R Gaither; Karen Wang; Steven M Asch; Donald Keith McInnes; Michael E Ohl; Kendall Bryant; Janet P Tate; Mona Duggal; David A Fiellin
Journal:  Clin Infect Dis       Date:  2015-09-03       Impact factor: 9.079
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.